The invisible pollution crisis in our homes and workplaces may be fundamentally altering how respiratory diseases develop and progress. Synthetic polymer particles smaller than 5 millimeters—ubiquitous in indoor air from carpet fibers, clothing, and household materials—are now recognized as active biological agents rather than inert contaminants.
This comprehensive review synthesizes mounting evidence that microplastic exposure contributes to lung cancer, asthma, COPD, and pulmonary fibrosis through five distinct molecular mechanisms. The particles trigger inflammatory cascades, generate reactive oxygen species, activate ferroptosis (iron-dependent cell death), promote epithelial-mesenchymal transition that enables cancer spread, and induce epigenetic modifications that alter gene expression. Particle size, polymer type, and environmental weathering significantly influence toxicity, with aged particles often proving more harmful than pristine ones.
The implications extend far beyond traditional air pollution concerns. Unlike cigarette smoke or industrial emissions that affect specific populations, microplastic exposure is universal and continuous, particularly in modern indoor environments where synthetic materials dominate. This suggests a paradigm shift from viewing environmental lung disease as primarily occupational or geographically confined to recognizing it as a consequence of ubiquitous modern materials.
The research reveals critical gaps in our understanding of dose-response relationships at realistic exposure levels and standardized measurement protocols. Given that microplastics persist indefinitely in lung tissue and accumulate over decades, their role as disease modifiers—accelerating or amplifying existing respiratory conditions rather than causing them outright—represents a new category of environmental health risk requiring urgent scientific and regulatory attention.